IL-4, IL-10 and IL-13 down-regulate monocyte-chemoattracting protein-1 (MCP-1) production in activated intestinal epithelial cells

Clinical and Experimental Immunology

Volumn 111, Issue 1, 1998, Pages 152-157

  Kucharzik, T ^a   Lugering N ^a   Pauels, H G ^a   Domschke, W ^a   Stoll, R ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Caco 2; IL 10; IL 13; IL 4; Inflammatory bowel disease; Intestinal epithelial cells; MCP 1

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 1BETA; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; PRIORITY JOURNAL;

CACO-2 CELLS; CHEMOKINE CCL2; DOWN-REGULATION; HUMANS; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; INTESTINAL MUCOSA;

EID: 0031930615     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00481.x     Document Type: Article

References (34)

1. Schuerer-Maly CC, Eckmann L, Kagnoff MF, Falco T, Maly FE. Colonic epithelial cell lines as a source of interleukin-8: stimulation of inflammatory cytokines and bacterial lipopolysaccharide. Immunol 1994; 81:85-91.
2. Jung HC, Eckmann L, Yang SK, Panja A, Fierer J, Morzyckka-Wroblewska E, Kagnoff MF. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995; 95:55-65.
3. Reinecker HC, Loh EY, Ringler DJ, Mehta A, Rombeau JL, Mac Dermott RP. Monocyte-chemoattractant protein I gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterol 1995; 108:40-50.
4. Qiao L, Vassiliki K, Tsioulias GJ, Koutsos MI, Hanif R, Shiff SJ, Rigas B. Selected eicosanoids increase the proliferation rate of human colon carcinoma cell lines and mouse colonocytes in vivo. Biochim Biophys Acta 1995; 1258:215-23.
5. Rigas B, Goldman IS, Levine L. Altered eicosanoid levels in human colon cancer. J Lab Clin Med 1993; 122:518-23.
6. Lamprecht SA, Schwartz B, Glicksman A. Transforming growth factor-beta in intestinal epithelial differentiation and neoplasia (review). Anticancer Res 1989; 9:1877-81.
7. Anzano MA, Rieman D, Prichett W, Bowen DF, Greig R. Growth factor production by human colon carcinoma cell lines. Cancer Res 1989; 49:2898-904.
8. Shirota K, LeDuy L, Yuan S, Jotha S. Interleukin-6 and its receptor are expressed in human intestinal epithelial cells. Virchows Arch B Cell Pathol Incl Mol Pathol 1990; 58:303-8.
9. Hirsch T, Eggstein S, Frank S, Farthmann EH, v Specht B-U. Expression of GM-CSF and a functional GM-CSF receptor in the human colon carcinoma cell line SW403. Biochem Biophys Res Commun 1995; 217:138-43.
10. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein-1 (MCP-1). Immunol Today 1990; 11:97-101.
11. Grimm MC, Elsbury SK, Pavli P, Doe WF. Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J Leukoc Biol 1996; 59:804-12.
12. Eckmann L, Chae Jung H, Schürer-Maly C, Pasit A, Morzycka-Wroblewska E, Kagnoff MF. Differential cytokine expression by human intestinal epithelial cell lines: regulated expression of interleukin-8. Gastroenterol 1993; 105:1689-97.
13. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Ann Rev Immunol 1993; 11:165-90.
14. 2. Proc Natl Acad Sci USA 1989; 86:3803.
15. Zurawski G, de Vries JE. Interleukin-13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994; 15:19-26.
16. Kucharzik T, Lügering N, Weigelt H, Adolf M, Domschke W, Stoll R. Immunoregulatory properties of interleukin-13 in patients with inflammatory bowel disease. Comparison with interleukin-4 and interleukin-10. Clin Exp Immunol 1996; 104:483-90.
17. Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis. Clin Exp Immunol 1995; 99:331-9.
18. Schreiber S, Heinig T, Panzer U, Reinking R, Bouchard A, Stahl PD, Raedler A. Impaired response of activated mononucleur phagocytes to interleukin-4 in inflammatory bowel disease. Gastroenterol 1995; 108:21-33.
19. Schreiber S, Heinig T, Thiele H-G, Raedler A. Immunoregulatory role of interleukin-10 in patients with inflammatory bowel disease. Gastroenterol 1995; 108:1434-44.
20. Hart PH, Ahern MJ, Jones CA, Jones KL, Smith MD, Finlay-Jones JJ. Synovial fluid macrophages and blood monocytes differ in their responses to IL-4. J Immunol 1993; 51:3370-80.
21. Kucharzik T, Lügering N, Adolf M, Domschke W, Stoll R. Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease. Dig Dis Sci 1997; 42:805-12.
22. Toi M, Bicknell R, Harris AL. Inhibition of colon and breast carcinoma cell growth by interleukin-4. Cancer Res 1992; 52:275-9.
23. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene "intercrine" cytokine family. Ann Rev Immunol 1991; 9:617-48.
24. Kolios G, Robertson DAF, Westwick J. Interleukin-13 regulates the nitric oxide production in human colonic epithelial cells. Comparison with interleukin-4 and interleukin-10. Gastroenterology 1996; A206.
25. Cominelli F, Nast CC, Clark BD, Schindler R, Lierena R, Eysselein VE, Thompson RC, Dinarello CA. Interleukin-1 gene expression, synthesis, and effect of specific IL-1β receptor blockade in rabbit immune complex colitis. J Clin Invest 1990; 86:972-80.
26. Mahida YR, Wu K, Jewell DP. Enhanced production of interleukin-1β by mononuclear cells isolated from mucosa with active ulcerative colitis and Crohn's disease. Gut 1989; 30:835-8.
27. Murata T, Noguchi PD, Puri PK. IL-13 induces phosphorylation and activation of JAK 2 Janus Kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. J Immunol 1996; 156:2972-8.
28. Berkman N, Robichaud A, Krishnan VL, Roesems G, Robbins R, Jose PJ, Barnes PJ, Chung KF. Expression of RANTES in human airway epithelial cells: effect of corticosteroids and interleukin-4, -10 and -13. Immunol 1996; 87:599-603.
29. Kucharzik T, Stoll R, Lügering N, Domschke W. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease. Clin Exp Immunol 1995; 100:452-6.
30. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995; 101:428-35.
31. West GA, Matsuura T, Levine AD, Klein JS, Fiocci C. Interleukin-4 in inflammatory bowel disase. Gastroenterol 1995; 108:1683-95.
32. Kühn R, Löhler J, Rennick D, Rajewsky K, Müller W. Interleukin-10 deficient mice develop chronic enterocolitis. Cell 1993; 75:263-74.
33. Herfarth HH, Mohanty SP, Rath HC, Tonkonogy S, Sartor RB. Interleukin-10 suppresses experimental chronic, granulomatous inflammation induced by bacterial cell wall polymers. Gut 1996; 39:836-45.
34. Duchmann R, Schmitt E, Knolle P, Meyer zum Büschenfelde KH, Neurath M. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996; 26:934-8.